Pseudotumorous reaction to hemostatic material. A new treatment approach illustrated by clinical cases
https://doi.org/10.64265/sibneuro-2025-1-1-68-77
Abstract
Introduction. Effective hemostasis is crucial in neurosurgical operations at the tumor/brain interface, where classical methods of bleeding control may be insufficient. The widely used oxidized cellulose material (Surgicel®, one of the most popular materials used in our operating rooms) rarely causes granulomatous reactions that can mimic tumor recurrence or an abscess. Objective of the study was to review two clinical cases of an inflammatory reaction to a hemostatic agent with successful conservative treatment and to discuss the existing literature on this issue.
Materials and methods. We present the clinical cases of two patients (17 and 10 years old) who underwent neurosurgical operations using oxidized cellulose hemostatic agents, after which an inflammatory reaction to the material developed. In both cases, anti-inflammatory therapy with prednisolone was administered, leading to the complete regression of symptoms, including radiological findings.
Results. Both patients exhibited a typical clinical picture of an inflammatory reaction to the hemostatic material, confirmed by neuroimaging (MRI) and laboratory data. Anti-inflammatory treatment with prednisolone provided a rapid therapeutic effect, avoiding the need for reoperation.
Conclusions. A reaction to the hemostatic material, such as granulomatous inflammation, requires careful differential diagnosis from tumor recurrence and abscess. In stable cases, successful conservative treatment is possible, avoiding unnecessary surgical interventions.
About the Authors
Yu. V. KushelRussian Federation
Yuri V. Kushel – Dr. Sci. (Med.), Neurosurgeon, Leading Researcher of the 2nd Neurosurgical Department (Pediatric Neurosurgery)
4ya Tverskaya-Yamskaya str., 16, Moscow, 125047
E. I. Konovalova
Russian Federation
Elizaveta I. Konovalova – Cand. Sci. (Med.), Neurosurgeon of the 2nd Neurosurgical Department (Pediatric Neurosurgery)
4ya Tverskaya-Yamskaya str., 16, Moscow, 125047
M. O. Demin
Russian Federation
Maxim O. Demin – Cand. Sci. (Med.), Neurosurgeon of the 2nd Neurosurgical Department (Pediatric Neurosurgery)
4ya Tverskaya-Yamskaya str., 16, Moscow, 125047
References
1. Huang L, Liu GL, Kaye AD, Liu H. Advances in topical hemostatic agent therapies: A comprehensive update. Adv Ther. 2020; 37(10): 4132-4148. https://doi.org/10.1007/s12325-020-01467-y
2. Rho SY, Jin M, Kim HK, Park JI, Park JH, Yun S, et al. The novel use and feasibility of hemostatic oxidized regenerated cellulose agent (SurgiGuard®): Multicenter retrospective study. Gland Surg. 2023; 12(7): 905-916. https://doi.org/10.21037/gs-22-675
3. Scarff JE, Stookey B, Garcia F. The use of dry oxidized cellulose as a primary hemostatic agent in neurosurgery. J Neurosurg. 1949; 6(4): 304-306. https://doi.org/10.3171/jns.1949.6.4.0304
4. Ereth MH, Schaff M, Ericson EF, Wetjen NM, Nuttall GA, Oliver WC Jr. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Neurosurgery. 2008; 63(4 Suppl 2): 369-372; discussion 372. https://doi.org/10.1227/01.NEU.0000327031.98098.DD
5. Agudelo-Arrieta M, Sierra Peña JA, Suárez MJ, Omaña-Álvarez L, Feo Lee OH. Brain surgiceloma and concomitant brain abscess by cutibacterium acnes: A case report. Interdiscip Neurosurg Adv Tech Case Manag. 2023; (31): 101684. https://doi.org/10.1016/j.inat.2022.101684
6. Buckley SC, Broome JC. A foreign body reaction to Surgicel(R) mimicking an abscess or tumour recurrence. Br J Neurosurg. 1995; 9(4): 561-563. https://doi.org/10.1080/02688699550041241
7. Kothbauer KF, Jallo GI, Siffert J, Jimenez E, Allen JC, Epstein FJ. Foreign body reaction to hemostatic materials mimicking recurrent brain tumor. Report of three cases. J Neurosurg. 2001; 95(3): 503-506. https://doi.org/10.3171/jns.2001.95.3.0503
8. Ribalta T, McCutcheon IE, Neto AG, Gupta D, Kumar AJ, Biddle DA, et al. Textiloma (gossypiboma) mimicking recurrent intracranial tumor. Arch Pathol Lab Med. 2004; 128(7): 749-758. https://doi.org/10.5858/2004-128-749-TGMRIT
9. Sandhu GS, Elexpuru-Camiruaga JA, Buckley S. Oxidized cellulose (Surgicel) granulomata mimicking tumour recurrence. Br J Neurosurg. 1996; 10(6): 617-619. https://doi.org/10.1080/02688699646989
10. Franceschini G, Visconti G, Di Leone A, Masetti R. “Warning” to postoperative complications when using hemostatic agents! Acta Neurochir (Wien). 2019; 161(5): 871-872. https://doi.org/10.1007/s00701-019-03863-y
11. Li B, Pan W, Sun X, Qin K, Bai G, Bao H, et al. Hemostatic effect and safety evaluation of oxidized regenerated cellulose in total knee arthroplasty – a randomized controlledtrial. BMC Musculoskelet Disord. 2023; 24(1): 797. https://doi.org/10.1186/s12891-023-06932-7
12. Capozza M, Pansini G, Buccoliero AЮ, Barbagli G, Ashraf-Noubari B, Mariotti F, et al. Foreign body reaction mimicking intracranial abscess following the use of oxidized regenerated cellulose (SurgicelTM): Case report and literature review. Iranian J Neurosurg. 2016; (2): 20–23. https://doi.org/10.18869/acadpub.irjns.2.2.20
13. Kleine J, Leisz S, Ghadban C, Hohmann T, Prell J, Scheller C, et al. Variants of oxidized regenerated cellulose and their distinct effects on neuronal tissue. Int J Mol Sci. 2021; 22(21): 11467. https://doi.org/10.3390/ijms222111467
Review
For citations:
Kushel Yu.V., Konovalova E.I., Demin M.O. Pseudotumorous reaction to hemostatic material. A new treatment approach illustrated by clinical cases. Sibneuro. 2025;1(1):68-77. (In Russ.) https://doi.org/10.64265/sibneuro-2025-1-1-68-77
